The largest database of trusted experimental protocols

Tla 120.2 fixed angle rotor

Manufactured by Beckman Coulter
Sourced in United States, United Kingdom

The TLA 120.2 fixed-angle rotor is a laboratory centrifuge rotor designed for use with Beckman Coulter's ultracentrifuge systems. It is capable of achieving high-speed centrifugation with a maximum speed of 120,000 rpm and a maximum relative centrifugal force (RCF) of 622,000 x g. The rotor is constructed with a fixed-angle design and can accommodate a variety of sample tube sizes, making it suitable for a range of applications requiring high-speed separation and analysis of biological samples.

Automatically generated - may contain errors

8 protocols using tla 120.2 fixed angle rotor

1

Affinity Purification of Ribosome-Nascent Chain Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro translation reactions (4 × 500 μl) were loaded onto 500 μl sucrose cushion (750 mM sucrose) in Buffer C (50 mM HEPES, 250 mM KOAc, 10 mM MgOAc, 0.1% DDM, 1/1,000 complete protease inhibitor (Roche), 0.2 U ml−1 RNasin, pH 7.2 at 4 °C) and centrifuged for 150 min (45,000 r.p.m., 4 °C) in a Beckman Coulter TLA 120.2 fixed-angle rotor. Pellets were resuspended in 4 × 300 μl 250 mM sucrose in ice cold buffer C and loaded onto a Talon metal affinity chromatography column (750 μl resin) pre-equilibrated in 10 ml buffer C containing 10 μg μl−1 bulk tRNA. The column was washed with 25 ml buffer C until no significant absorption (A260) could be detected in the wash fractions. The MifM-SRC, bound to the Talon matrix by MifM's N-terminal 8 × His-tag, was eluted in 4 × 500 μl buffer C containing 150 mM Imidazole. The eluate was loaded onto 10–40% sucrose gradients (prepared with buffer C) and centrifuged for 13 h in a Beckman coulter SW40 Ti swinging bucket rotor (20,000 r.p.m., 4 °C). Gradients were separated on a Biocomp Gradient Station ip and fractions containing 70S ribosomal particles were collected and pelleted for 3 h in a Beckman Coulter TLA 120.2 fixed-angle rotor (45,000 r.p.m., 4 °C). The MifM-SRC pellet was resuspended in 28 μl 30 mM sucrose in buffer C, on ice (69 OD ml−1), aliquoted and snap-frozen. Samples were further analysed by SDS–PAGE and western blotting.
+ Open protocol
+ Expand
2

Ribosome Purification and Protein Enrichment

Check if the same lab product or an alternative is used in the 5 most similar protocols
500 μL in vitro translation reaction was loaded onto 10–50% sucrose gradient prepared with Buffer C (25 mM pH 7.2 HEPES-KOH, 100 mM KOAc, 10 mM Mg(OAc)2, 0.01% DDM, 1/1,000 complete protease inhibitor (Roche, Germany), 0.2 U/mL RNase, 2 mM 2-mercaptoethanol) and centrifuged for 3 hr in a Beckman coulter SW40 Ti swinging bucket rotor with 35,000 r.p.m. at 4°C. Gradients were separated on a Biocomp Gradient Station and fractions containing 70S ribosomal particles were collected and loaded onto a Talon metal affinity chromatography column (1.5 ml resin) pre-equilibrated in 10 mL buffer C containing 10 μg/mL bulk tRNA. The column was washed with 25 ml buffer C until no significant absorption (OD260) could be detected in the wash fractions. The VemP-SRC, bound to the Talon matrix by the VemP N-terminal His-tag, was eluted in 750 μL buffer C containing 150 mM imidazole. The elution was pelleted for 4 hr 20 min in a Beckman Coulter TLA 120.2 fixed-angle rotor with 51,000 r.p.m. at 4°C. 15.6 pmol VemP-SRC pellet was resuspended in ice-cold buffer C without DDM, aliquoted and snap-frozen.
+ Open protocol
+ Expand
3

Lipoprotein Fractionation by Ultracentrifugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Duplicate samples of freshly-collected EDTA-plasma were used to separate the three major lipoprotein classes by sequential, isopycnic centrifugation in a TLA-120.2 fixed angle rotor (Beckman, Fullerton, CA), as described previously [55 (link)]. Density (r) adjustments were made with stock solutions of KBr in 0.15 M NaCl and four fractions were obtained: very-low density lipoproteins (VLDL; r <1.006 g/L), low-density lipoproteins (LDL; r: 1.006–1.063 g/L), high-density lipoproteins (HDL; r: 1.063–1.21 g/L), and very-high-density lipoproteins (r>1.21 g/L, which also include bulk plasma proteins). Each fraction was collected, extensively dialyzed against 150 mM NaCl/ 0.24 mM EDTA pH 7.4 at 4°C and filtered through 0.22 μm-pore size filters (Millipore S.A., St Quentin, France).
+ Open protocol
+ Expand
4

Purification of HCV Particles from Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
To purify HCV particles from serum, 10 mL of pooled serum samples from either 20 HCV-infected patients or 20 healthy carriers were used for this study. After filtration through two layers of gauze, serum was centrifuged without adjustment of density for 1 h at 436,000 x g at 4°C in a TLA-120.2 fixed angle rotor (Beckman, Fullerton, CA). After centrifugation, three fractions were respectively recovered: the yellow cake (VLDL) phase located over the supernatant, the supernatant and the pellet. The VLDL fraction was resuspended in 0.15 M NaCl solution and the centrifugation was repeated twice and stored for further analyses. The pellet was suspended in PBS buffer and re-centrifuged twice under the same conditions. The final pellet was resuspended in a final PBS volume corresponding to a 1/10 of the initial serum volume. One hundred microliter portions of these HCVp concentrates were layered onto 900 μL of either a sucrose or a CsCl gradient [10–60% (w/w)] and centrifuged for 18 h at 300,000 x g at 4°C.
+ Open protocol
+ Expand
5

Isolation of Extracellular Vesicles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasma (1 mL) was centrifuged
in a 1.2 mL polycarbonate ultracentrifuge for 120 min at 120,000g and 4 °C in a TLA-120.2 fixed-angle rotor (Beckman
Coulter). The resulting pellet was resuspended in 1 mL of PBS and
centrifuged at 120,000g at 4 °C for 90 min in
a TLA-120.2 fixed-angle rotor for washing. Finally, the pellets were
resuspended in PBS.
+ Open protocol
+ Expand
6

Isolation and Purification of Exosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
2 mL aliquots were processed according to a protocol adapted from Théry et al.10 (link). To remove large debris, BT474 media was centrifuged at 2,000 × g for 20 minutes and the pellet discarded. The supernatant was centrifuged at 10,000 × g for a further 30 minutes and the resulting pellet discarded. Samples were transferred to 3.5 mL polycarbonate ultracentrifuge tubes (Beckman Coulter, USA) and centrifuged for 70 minutes at 4°C and 100 000 × g in a TLA100.3 fixed angle rotor (Beckman Coulter, USA). The resulting pellets were resuspended in 1 mL PBS and transferred to 1 mL polycarbonate ultracentrifuge tubes (Beckman Coulter, USA). To concentrate the exosomes, samples were centrifuged at 4°C and 100 000 × g for 60 minutes in a TLA120.2 fixed angle rotor (Beckman Coulter, USA). The resulting pellet was resuspended in 100 µL PBS and stored at 4°C. The purification process for liposomes was identical with omission of the initial centrifugation steps for removal of debris.
+ Open protocol
+ Expand
7

Cholesterol Measurement and Lipoprotein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cholesterol (TC) was measured using the cholesterol oxidase phenol 4-aminoantipyrine peroxidase method, triglycerides (TG) by the glycerol phosphate oxidase phenol 4-aminoantipyrine peroxidase method, and apolipoprotein A1 (apo-A1) and apolipoprotein B (apo B) were assayed using immunoturbidimetric assays (ABX Diagnostics, Shefford, UK). High-density lipoprotein cholesterol (HDL-C) was assayed using a second-generation homogenous direct method (Roche Diagnostics, Burgess Hill, UK). All these tests were performed on a Cobas Mira analyser (Horiba ABX Diagnostics, Nottingham, UK). The laboratory participated in the RIQAS (Randox International Quality Assessment Scheme; Randox Laboratories, Dublin, Ireland) scheme which is CRC calibrated. Low-density lipoprotein cholesterol (LDL-C) was estimated using the Friedewald formula. Non-HDL-C was estimated using the formula: non-HDL-C = (TC) − (HDL-C).
Small-dense LDL apolipoprotein B (sdLDL apoB) (density range 1.044–1.063 g/mL) was isolated from plasma adjusted to density of 1.044 g/mL and ultracentrifuged at 100,000 rpm (435,680 × g) for 5 h at 4°C using a Beckman Optima TLX bench top ultracentrifuge fitted with TLA 120.2 fixed angle rotor (Beckman Coulter UK) (19 (link)). ApoB in SdLDL was determined using the method described above.
+ Open protocol
+ Expand
8

Plasma Lipid Profiling by FPLC and Ultracentrifugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma samples were collected after 4 h of fasting and plasma total cholesterol and triglyceride levels were measured enzymatically using commercially available reagents (Roche Diagnostics, Mannheim, Germany) as reported previously [23 (link)]. Plasma samples were subjected to fast protein liquid chromatography gel filtration on an Äkta purifier equipped with a Superose 6 column (GE Healthcare, Little Chalfont, UK). Chromatography was done at a flow rate of 0.5 mL/min and lipoprotein fractions of 500 µL each were collected and assayed for cholesterol concentrations. Individual lipoprotein subclasses were isolated by tabletop sequential ultracentrifugation from 30 µL of plasma using a TLA-120.2 fixed-angle rotor (Beckman Coulter, Woerden, The Netherlands) and a 1.34 g/mL potassium bromide stock solution to adjust densities (densities, VLDL/IDL: 1.006 < d < 1.019, LDL: 1.019 < d < 1.063, HDL: 1.063 < d < 1.21; each run 3 h at 100,000 rpm). After extensive dialysis against PBS, cholesterol concentrations within individual fractions were determined using a commercial colorimetric assay (Roche Diagnostics).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!